Voyager Technologies is positioned for upside if it transitions from R&D-heavy contracts to scaled, repeatable production.

LEXINGTON, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it has decided to ...

- All other programs remain on track; IND filings expected in 2025 for GBA1 and FA programs - LEXINGTON, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (VYGR), a biotechnology ...

WASHINGTON — The Defense Advanced Research Projects Agency awarded Voyager Technologies a $16.5 million contract to continue development of a solid rocket motor thrust-control technology designed to ...

'We realize that Voyager means a lot to people and we are doing our best to keep them going for as long as possible.' By Andrew Paul Published Dec 14, 2023 11:35 AM EST Add Popular Science (opens in a ...

Voyager Therapeutics Inc (NASDAQ:VYGR) is one of the best gene therapy stocks to buy in 2026. While the stock has risen only ...

For nearly five decades, NASA's twin Voyager probes have plumbed the cosmos in search of answers to some of astronomy's most perplexing mysteries about our solar system and its place in the wider ...

NEW YORK, Nov. 13, 2024 /PRNewswire/ -- Sourcepass, an innovative IT Services and Cybersecurity provider, is proud to announce that they have been named an inaugural member of the Galactic level of ...

Contrary to its name, Voyager 2 was the first of the vehicles launched into space first in Aug. 20 1977 from Florida. Its twin probe, Voyager 1, launched two weeks later on Sept. 5. At more than 15 ...